Learn about pediatric low-grade glioma symptoms, causes, diagnosis, and treatment. Understand risk factors and prevention to ...
Veliparib plus temozolomide did not significantly extend overall survival in patients with newly diagnosed, ...
Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with ...
News Medical on MSN5h
Scientists discover new target for treating aggressive brain cancerA study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...
Chen recommended a minimally invasive procedure that uses heat to target the remaining tumor cells. This technique, done in ...
A woman was diagnosed with a brain tumor after she couldn’t read a single letter during her eye test. Gemma Hillier, 45, lost ...
ONC-206 is under clinical development by Chimerix and currently in Phase I for High-Grade Glioma. According to GlobalData, Phase I drugs for High-Grade Glioma does not have sufficient historical data ...
Ibrance is under clinical development by Pfizer and currently in Phase II for Pediatric Diffuse Intrinsic Pontine Glioma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback